Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

BFRIW

Biofrontera (BFRIW)

Biofrontera Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:BFRIW
DatumZeitQuelleÜberschriftSymbolFirma
14/06/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIWBiofrontera Inc
22/05/202422h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BFRIWBiofrontera Inc
22/05/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIWBiofrontera Inc
15/05/202423h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIWBiofrontera Inc
10/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BFRIWBiofrontera Inc
16/12/202214h30GlobeNewswire Inc.Biofrontera Inc. Announces Voting Results from 2022 Annual Meeting of StockholdersNASDAQ:BFRIWBiofrontera Inc
30/11/202220h08GlobeNewswire Inc.Biofrontera Inc. to Participate in Benchmark’s 11th Annual Discovery One-on-One Investor ConferenceNASDAQ:BFRIWBiofrontera Inc
28/11/202217h05GlobeNewswire Inc.BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022NASDAQ:BFRIWBiofrontera Inc
21/11/202214h48GlobeNewswire Inc.Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and TrunkNASDAQ:BFRIWBiofrontera Inc
14/11/202214h45GlobeNewswire Inc.Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business UpdateNASDAQ:BFRIWBiofrontera Inc
10/11/202217h52GlobeNewswire Inc.Biofrontera Inc. to Report Third Quarter Financial Results on November 14, 2022NASDAQ:BFRIWBiofrontera Inc
08/11/202222h45GlobeNewswire Inc.Biofrontera Inc. Fully Exercises Recently Acquired Options to Purchase Shares of Biofrontera AGNASDAQ:BFRIWBiofrontera Inc
31/10/202213h55GlobeNewswire Inc.Biofrontera Inc. Enters into Agreements to Purchase Options of Biofrontera AGNASDAQ:BFRIWBiofrontera Inc
24/10/202213h45GlobeNewswire Inc.Biofrontera Inc. Names Fred Leffler as Chief Financial OfficerNASDAQ:BFRIWBiofrontera Inc
20/10/202217h40GlobeNewswire Inc.Biofrontera Inc. to Present at the LD Micro Main Event XV Investor ConferenceNASDAQ:BFRIWBiofrontera Inc
18/10/202216h30GlobeNewswire Inc.Biofrontera Inc. to Sponsor the 2022 Fall Clinical Dermatology ConferenceNASDAQ:BFRIWBiofrontera Inc
14/10/202214h40GlobeNewswire Inc.Biofrontera Inc. Adopts Limited Duration Shareholder Rights PlanNASDAQ:BFRIWBiofrontera Inc
12/10/202220h00GlobeNewswire Inc.BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON FRIDAY OCTOBER 14, AND TUESDAY OCTOBER 18, 2022NASDAQ:BFRIWBiofrontera Inc
05/10/202223h00GlobeNewswire Inc.Biofrontera Inc. Announces Preliminary Product Revenues for the Third Quarter of 2022NASDAQ:BFRIWBiofrontera Inc
29/09/202216h04GlobeNewswire Inc.Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities ConferenceNASDAQ:BFRIWBiofrontera Inc
26/09/202214h30GlobeNewswire Inc.Biofrontera Inc.’s Marketing Campaign and Website for Ameluz Won 2022 PM360 Trailblazer AwardsNASDAQ:BFRIWBiofrontera Inc
13/09/202214h30GlobeNewswire Inc.Biofrontera Inc. Names Gerard DiGirolamo as National Sales DirectorNASDAQ:BFRIWBiofrontera Inc
06/09/202216h31GlobeNewswire Inc.Biofrontera Inc. Announces Notice of Allowance for Nanoemulsion Composition-of-Matter U.S. PatentNASDAQ:BFRIWBiofrontera Inc
18/08/202217h04GlobeNewswire Inc.Biofrontera Inc.’s Leslie Hopkins Named PM360 Trailblazer 2022 Brand Champion for DermatologyNASDAQ:BFRIWBiofrontera Inc
12/08/202214h33GlobeNewswire Inc.Biofrontera Inc. Reports Second Quarter 2022 Financial Results and Provides a Business UpdateNASDAQ:BFRIWBiofrontera Inc
04/08/202214h30GlobeNewswire Inc.Biofrontera Inc. to Report Second Quarter Financial Results on August 12, 2022NASDAQ:BFRIWBiofrontera Inc
01/08/202217h00GlobeNewswire Inc.Biofrontera Inc. Announces Patent in Australia for Novel Illumination Protocols Granted to Biofrontera Bioscience GmbHNASDAQ:BFRIWBiofrontera Inc
27/07/202214h45GlobeNewswire Inc.Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private PlacementNASDAQ:BFRIWBiofrontera Inc
12/07/202214h00GlobeNewswire Inc.Biofrontera Inc. Announces Preliminary Product Revenues for the Second Quarter of 2022NASDAQ:BFRIWBiofrontera Inc
09/06/202215h44GlobeNewswire Inc.Biofrontera, Inc. Recognized for Rapid Sales Growth, Innovative Therapies and Marketing ExcellenceNASDAQ:BFRIWBiofrontera Inc
 Showing the most relevant articles for your search:NASDAQ:BFRIW